Introduction {#S1}
============

In vertebrates, the cranial base lies below the brain and forms a central bone structure of the skull. Within the cranial base, synchondroses play a critical role in the longitudinal growth of the skull ([@B41]; [@B62]). Precocious ossification and/or malformation of cranial synchondroses can induce the fusion of adjacent bones and subsequent cranium deformities, such as microcephaly and midface hypoplasia ([@B17]; [@B16]). In order to understand the nature of craniofacial development and related congenital anomalies, identifying the signaling molecules that regulate synchondrosis development is necessary.

Cartilaginous segments that persist between the ossification centers in the cranial base represent various synchondroses, such as the sphenoethmoidal synchondrosis, intersphenoid synchondrosis (ISS), spheno-occipital synchondrosis (SOS), and intraoccipital synchondrosis ([Figure 1A](#F1){ref-type="fig"}). The ISS is located between the presphenoid and basisphenoid bones in the central region of the cranial base, while the SOS is located between the basisphenoid and basioccipital bones ([Figures 1A,B](#F1){ref-type="fig"}). The medial line of the cranial base is originally composed of the hypophyseal, acrochordal, and parachordal cartilages ([@B41]). Subsequently, the hypophyseal cartilage and acrochordal cartilage develop into the ISS and SOS, respectively ([@B41]). The cartilage primordium of the ISS is derived from the neural crest, whereas the SOS has a more complex origin, wherein its cartilage primordium is derived from the neural crest as well as the cranial mesoderm ([Figure 1C](#F1){ref-type="fig"}; [@B41]). The SOS contributes to the embryonic and postnatal elongation of the cranial base, until its ossification between the ages of 16 and 18 years in humans, whereas complete ossification of the ISS occurs between 2 and 3 years of age ([@B38]), suggesting that the role of the SOS, in particular, is important in the postnatal stage.

![The cranial base and synchondroses. **(A)** Ventral view of bone staining of the mouse cranial base at postnatal day (P) 0. The middle line of the cranial base is formed by the presphenoid, basisphenoid (BS), and basioccipital (BO) bones. Between the mineralized bones, there are two cartilaginous synchondroses, the intersphenoid synchondrosis (ISS) and the spheno-occipital synchondrosis (SOS). Please note that the presphenoid bone is invisible because of the palatine process (PA). AT, ala temporalis (greater wing) of the basisphenoid bone; CA, canalicular part of auditory capsule; EO, exoccipital bone; FB, facial bone; IOSA, intraoccipital synchondrosis; SAB, synchondrosis, alar-basisphenoidalis; SES, spheno-ethmoidal synchondrosis. **(B)** Safranin-O staining of the mouse cranial base at embryonic day (E) 16.5. The presphenoid (PS), basisphenoid (BS), and basioccipital (BO) bones are separated by two synchondroses, the intersphenoid synchondrosis (ISS) and spheno-occipital synchondrosis (SOS). The synchondrosis is composed of bipolar growth plates with a central resting (r), proliferating (p), and prehypertrophic (ph) zones. PA, palate; Rp, Rathke's pouch. **(C)** Schematic illustration of the tissue origins of the cranial base derived from the neural crest shown in red and those derived from the mesoderm in blue ([@B41]). BS, basisphenoid bone; BO, basioccipital bone; EO, exoccipital bone; PS, presphenoid bone. **(D)** STRING protein-protein interaction network of mouse genes involved in abnormal synchondroses. The network was constructed using the STRING tool^[3](#footnote3){ref-type="fn"}^, with mouse genes involved in abnormal synchondroses ([Table 1](#T1){ref-type="table"}) used as input. Different colors represent different kinds of evidence of connection between proteins. **(E) (a)** Skulls from wild-type and *Tbx1*-deficient mice at birth were analyzed by micro-computed tomography and are shown in a "bird's eye view." In *Tbx1*-deficient mice, the spheno-occipital synchondrosis (SOS) was completely mineralized ([@B16]). BO, basioccipital bone; BS, basisphenoid bone; ISS, intersphenoid synchondrosis; PA, palatine process. **(b)** A predicted model for TBX1-mediated regulation of endochondral ossification of SOS. By inhibiting the activity of RUNX2 and the expression of RUNX2 target genes, TBX1 negatively regulates chondrocyte differentiation as well as subsequent endochondral ossification in the SOS.](fcell-08-00706-g001){#F1}

The cranial base is formed by endochondral ossification, which begins with the formation of a cartilage primordium from condensed mesenchymal cells ([@B41]). Chondrocyte proliferation maintains the synchondroses and leads to elongation of the cranial base ([@B40]). Immature chondrocytes undergo hypertrophy and subsequent apoptosis, followed by the formation of ossification centers after the invasion of osteoblasts from the perichondrium ([@B56]). Endochondral ossification of the cranial synchondroses is different from that of skeletal bones in several ways. The synchondrosis is composed of bipolar growth plates with resting, proliferating, pre-hypertrophic, and hypertrophic zones that produce growth in opposing directions, whereas long bones are composed of a unipolar growth plate ([@B61]). This review presents new insights on the signaling pathways and transcription factors involved in the regulation of synchondrosis development, highlighting the differences and similarities between synchondroses present in the cranial base.

Signaling Pathways in Synchondrosis Development {#S2}
===============================================

For the normal progression of the development of synchondroses, stringent regulation of chondrocyte differentiation in the cranial synchondroses is crucial. To find the relationship between genetic or molecular interaction networks in the synchondroses, genetically modified mice associated with abnormal synchondroses were investigated. Using the Mouse Genome Informatics^[1](#footnote1){ref-type="fn"}^ database and PubMed^[2](#footnote2){ref-type="fn"}^, 31 mouse genes with abnormal annotations in SOS and/or ISS were discovered ([Table 1](#T1){ref-type="table"}). These genes indicated that the regulation of synchondrosis development involves the interaction of several signaling pathways, including the parathyroid hormone-like hormone (PTHLH)/parathyroid hormone-related protein (PTHrP), Indian hedgehog (Ihh), Wnt/β-catenin, and fibroblast growth factor (FGF) pathways, as well as control by cilium assembly and by transcription factors encoded by specific genes ([Figure 1D](#F1){ref-type="fig"}). This review focuses on the genes listed in [Table 1](#T1){ref-type="table"}.

###### 

Mouse genes involved in abnormal development of the cranial synchondroses.

  Gene             Protein                                                          Induced mutation type     SOS/ISS    Age                  Ossification          References
  ---------------- ---------------------------------------------------------------- ------------------------- ---------- -------------------- --------------------- ----------------
  *Tbx1*           T-box 1                                                          Deletion (*Mesp1-Cre*)    SOS        E15.5                Partially increased   [@B16]
  *Fgfrl1*         FGF receptor like 1                                              Deletion                  SOS        E18.5                Increased             [@B5]
  *Ihh*            Indian hedgehog                                                  Deletion (*Col2a1-Cre*)   SOS        E18.5                Increased             [@B50]
  *Mef2c*          myocyte enhancer factor 2C                                       Activation                SOS        E18.5                Increased             [@B2]
  *Pth1r*          parathyroid hormone 1 receptor                                   Deletion                  SOS        E18.5                Increased             [@B33]
  *Six1*; *Six4*   sine oculis-related homeobox 1; sine oculis-related homeobox 4   Deletion                  SOS        E18.5                Partially increased   [@B18]
  *Chrd*           chordin                                                          Deletion                  SOS        P1                   Partially increased   [@B3]
  *Por*            P450 oxidoreductase                                              Deletion (*Dermo1-Cre*)   SOS        P4                   Partially increased   [@B49]
  *Nppc*           natriuretic peptide type C                                       Deletion                  SOS        P14                  Decreased             [@B44]
  *Twist1*         twist bHLH transcription factor 1                                Deletion (heterozygous)   SOS        P25-30               Increased             [@B19]
  *Evc*            EvC ciliary complex subunit 1                                    Deletion                  ISS        E18.5                Increased             [@B47]
  *Evc2*           EvC ciliary complex subunit 2                                    Deletion                  ISS        E18.5                Increased             [@B4]
  *Pkd2*           polycystin 2                                                     Deletion (*Wnt1-Cre*)     ISS        P14                  Increased             [@B26]
  *Lef1*           lymphoid enhancer binding factor 1                               Activation                ISS, SOS   E17.5                Increased             [@B43]
  *Ctnnb1*         catenin beta 1                                                   Deletion (*Col2a1-Cre*)   ISS, SOS   E17.5                Decreased             [@B43]
  *Arl6/Bbs3*      ADP-ribosylation factor-like 6                                   Deletion                  ISS, SOS   E18.5                Decreased             [@B25]
  *Pthlh/Pthrp*    parathyroid hormone-like peptide                                 Deletion                  ISS, SOS   P1                   Increased             [@B22]
  *Runx2*          runt-related transcription factor 2                              Activation                ISS, SOS   P1                   Increased             [@B58]
  *Six2*           sine oculis-related homeobox 2                                   Deletion                  ISS, SOS   P1                   Increased             [@B18]
  *Fgfr2*          fibroblast growth factor receptor 2                              Activation                ISS, SOS   P1 (SOS) P28 (ISS)   Increased             [@B42]
  *Pkd1*           polycystin 1                                                     Deletion (*Dermo1-Cre*)   ISS, SOS   P5                   Partially increased   [@B27]
  *Kif3a*          kinesin family member 3A                                         Deletion (*Col2a1-Cre*)   ISS, SOS   P7                   Partially increased   [@B29]
  *Hdac4*          histone deacetylase 4                                            Deletion                  ISS, SOS   P8                   Increased             [@B60]
  *Map2k1*         mitogen-activated protein kinase kinase 1                        Activation                ISS, SOS   P11                  Increased             [@B40]
  *Id2*            inhibitor of DNA binding 2                                       Deletion                  ISS, SOS   P14                  Growth defects        [@B53]
  *Ift88*          intraflagellar transport 88                                      Deletion (*Col2a1-Cre*)   ISS, SOS   P14                  Partially increased   [@B46]
  *Alpl*           alkaline phosphatase, liver/bone/kidney                          Deletion                  ISS, SOS   P20                  Increased             [@B37]; [@B45]
  *Ltbp3*          latent transforming growth factor beta binding protein 3         Deletion                  ISS, SOS   P21                  Increased             [@B10]
  *Fgfr3*          fibroblast growth factor receptor 3                              Activation                ISS, SOS   P21                  Increased             [@B6]
  *Pfas*           Phosphoribosyl-formylglycinamidine synthase                      Mutation (heterozygous)   n/a        P84                  Increased             [@B48]

E, embryonic day; P, postnatal day; SOS, spheno-occipital synchondrosis; ISS, intersphenoid synchondrosis; n/a, not available.

Runt-Related Transcription Factor 2 {#S2.SS1}
-----------------------------------

Runt-Related Transcription Factor 2 (*RUNX2*), a gene implicated in cleidocranial dysplasia (Online Mendelian Inheritance in Man; OMIM \#119600), is a crucial transcription factor of osteoblast and chondrocyte differentiation ([@B12]; [@B28]; [@B63]). Skull radiography of patients with cleidocranial dysplasia caused by *RUNX2* haploinsufficiency showed persistent synchondroses primarily associated with defective development of membranous bones ([@B31]; [@B1]). Chondrocyte-specific constitutive *Runx2* expression in mice has also been shown to induce precocious endochondral ossification in the cranial cartilage ([@B58]).

RUNX2 and histone deacetylase 4 (HDAC4) are expressed in prehypertrophic and hypertrophic chondrocytes present in developing cartilages. HDAC4 regulates chondrocyte differentiation and endochondral bone formation by interacting with and inhibiting the activity of RUNX2 ([@B21]; [@B13]; [@B60]). Furthermore, *Hdac4*-deletion mice exhibit precocious endochondral ossification of cranial synchondrosis ([@B60]). Myocyte enhancer factor 2C (MEF2C) regulates a *Runx2* enhancer in chondrocytes, and an activating form of MEF2C in mice causes precocious chondrocyte hypertrophy as well as ossification in SOS ([@B2]). *Runx2* expression has been detected in the cartilaginous condensation of the cranial cartilages at embryonic day 13.5 ([@B16]), yet ossification of synchondroses did not occur in the wild-type embryos. This time lag between *Runx2* expression and execution of chondrocyte differentiation in the synchondroses implies that multiple layers of regulation are required in synchondrosis development and that HDAC4 and MEF2C could be the regulators involved in this process.

T-Box Transcription Factor Family 1 {#S2.SS2}
-----------------------------------

T-box Transcription Factor Family 1 (*TBX1*) is the candidate gene of DiGeorge (OMIM \#188400), velocardiofacial (OMIM \#192430), and conotruncal anomaly face (OMIM \#217095) syndromes. *Tbx1*-deficient mice exhibit most features similar to the human syndromes, including microcephaly ([@B23]; [@B36]; [@B14], [@B15]). Mice lacking *Chrd---*which encodes chordin, i.e., an antagonist of bone morphogenetic proteins (BMPs)---exhibit recapitulating phenotypes of DiGeorge syndrome and *Tbx1*-deletion mice ([@B3]). Recently, we reported that TBX1 is a specific and essential regulator of chondrocyte differentiation and subsequent ossification at the SOS ([@B16]). By inhibiting the activity of RUNX2 and the expression of RUNX2 target genes, TBX1 negatively regulates chondrocyte differentiation and subsequent ossification in the SOS ([Figure 1E](#F1){ref-type="fig"}).

FGF Pathway {#S2.SS3}
-----------

The FGF receptor (FGFR) family is a subfamily of receptor tyrosinekinases. Dominant gain-of-function mutations of *FGFR2* induce craniofacial dysmorphology in Apert (OMIM \#101200), Crouzon (OMIM \#123500), Pfeiffer (OMIM \#101600), Jackson-Weiss (OMIM \#123150), and Antley-Bixler (OMIM \#207410) syndromes. Mice carrying the *Fgfr2* mutation exhibit accelerated chondrocyte maturation, accompanied by precocious ossification in the SOS and ISS synchondroses, at birth and 4 week-old stage, respectively ([@B42]). A patient with Antley-Bixler syndrome was also identified to be harboring a mutation in *FGFRL1* ([@B51]). *Fgfrl1-*deficient mice showed precocious ossification in the SOS at E18.5 ([@B5]). Homozygous mutations in the *POR* gene, encoding cytochrome P450 oxidoreductase, induce midface hypoplasia and craniosynostosis in Antley-Bixler syndrome, accompanied by genital anomalies and disordered steroidogenesis (OMIM \#201750). Conditional deletion of *Por* in osteoprogenitors with *Dermo1-Cre* affects synchondrosis and long bone development in mice recapitulating Antley-Bixler syndrome ([@B49]). Although the craniofacial dysmorphology caused by *POR* mutations and by *FGFR2* mutations overlap, the pathogenesis underlying the skeletal malformation in *POR* deficiency remains to be elucidated.

Gain-of-function mutation of *FGFR3* is reported in most cases of achondroplasia (OMIM \#100800) and Muenke syndrome (OMIM \#602849), which are associated with craniofacial and skeletal abnormalities. Targeted mutations in *Fgfr3* in mice carrying the equivalent human syndromes lead to decreased chondrocyte proliferation along with accelerated osteoblast differentiation, resulting in precocious ossification of synchondroses ([@B6], [@B7]; [@B40]; [@B34]). Additionally, chondrocyte-specific expression of constitutively active mitogen-activated protein kinase 1 (MAP2K1)/MEK1 causes precocious ossification of cranial synchondroses and effectively rescues the *Fgfr3*-deficient mouse phenotype ([@B40]).

PTHLH/PTHrP Pathway {#S2.SS4}
-------------------

PTHLH, also known as PTHrP, maintains chondrocyte proliferation in conjunction with parathyroid hormone 1 receptor (PTH1R). PTHLH/PTHrP impedes chondrocyte differentiation through the inhibition of *Runx2* expression ([@B35]). In *Pthlh/Pthrp*-deletion mice, chondrocyte differentiation is accelerated in both the SOS as well as the ISS ([@B22]). Moreover, PTHLH/PTHrP promotes dephosphorylation and nuclear localization of HDAC4, subsequently inhibiting MEF2C transcription ([@B30]). *Pth1r*-deletion mice are shown to exhibit abnormal neurocranium morphology due to excessive mineralization of synchondroses present between the basioccipital, exoccipital, and basisphenoid bones ([@B33]).

Ihh Pathway {#S2.SS5}
-----------

The Ihh pathway coordinates diverse aspects of bone morphogenesis via PTHLH/PTHrP-dependent and independent processes ([@B56]). Ihh is expressed in the synchondroses within the prehypertrophic chondrocytes via RUNX2 regulation and promotes chondrocyte proliferation as well as differentiation ([@B64]; [@B43]; [@B59]). In *Ihh*-deficient synchondroses, chondrocyte proliferation is decreased, and their differentiation is initially delayed ([@B50]; [@B64]). Furthermore, conditional deletion of *Ihh* with *Col2a1-Cre* results in loss of the SOS at E18.5 ([@B50]).

Cilium Assembly {#S2.SS6}
---------------

The hedgehog signaling pathway requires cilium assembly. Kinesin family member 3A (KIF3A) is an intraflagellar transport (IFT) motor protein essential for the formation of cilia ([@B20]). Conditional deletion of *Kif3a* with *Col2a1-Cre* results in precocious ossification of synchondroses, by disrupting the expression pattern of *Ihh* in synchondroses ([@B29]). Conditional deletion of *Ift88*, which encodes IFT88/polaris, ultimately results in a deformed basicranium, along with precocious ossification of synchondroses due to disruption of the Ihh signaling pathway ([@B46]). Polycystin-1 and polycystin-2, which are encoded by *Pkd1* and *Pkd2*, form a protein complex and localize to the primary cilium. Conditional deletion of *Pkd1* with *Dermo1-Cre* exhibits a premature closure of both the ISS and SOS ([@B27]), whereas conditional deletion of *Pkd2* in neural crest with *Wnt1-Cre* exhibits abnormal ossification of neural crest-derived ISS ([@B26]).

*EVC* and *EVC2* are the disease genes implicated in Ellis-van Creveld syndrome (OMIM \#225500) as well as Weyers acrofacial dysostosis (OMIM \#193530). EvC ciliary complex subunit 1 (EVC) and EVC2 localize at the base of chondrocyte cilia and function as positive regulators of Ihh-mediated bone development ([@B57]; [@B52]; [@B4]). Both *Evc*- and *Evc2*-deficient mice exhibit precocious ossification of the ISS at E18.5 ([@B47]; [@B4]).

ADP-ribosylation factor-like 6, which is encoded by *ARL6/BBS3*, regulates intracellular traffic. Mutations in *ARL6/BBS3* account for Bardet-Biedl syndrome-3 (OMIM \#600151), which is characterized by retinal dystrophy, renal structural abnormalities, history of obesity, and skeletal abnormalities. *Arl6/Bbs3*-deficient mice are shown to exhibit hypomorphic cranial synchondroses at E18.5 ([@B25]).

Wnt/β-Catenin Pathway {#S2.SS7}
---------------------

The Wnt/β-catenin and Ihh signaling pathways interact with one another to regulate the development of the endochondral bones ([@B39]). Conditional deletion of *Ctnnb1*, which encodes CTNNB1/β-catenin, with *Col2a1-Cre* results in abnormal bone formation ([@B11]; [@B43]). β-catenin and T-cell factor/lymphoid enhancer factor 1 (TCF/LEF1) are transcriptional mediators of the Wnt/β-catenin signaling pathway that directly interact with the *Ihh* promoter in chondrocytes *in vivo*, suggesting that the Wnt/β-catenin signaling pathway regulates *Ihh* expression ([@B55]). Cartilage overexpression of a constitutively active form of LEF1 causes accelerated chondrocyte hypertrophy, topographical disorganization, and excessive bone collar formation in the ISS and SOS ([@B43]). Interestingly, LEF1 is reported to interact with and consequently inhibit the activity of RUNX2 ([@B24]), suggesting that LEF1 might regulate RUNX2 activity during the development of synchondroses.

SIX Homeobox Family {#S2.SS8}
-------------------

The sine oculis homeobox (SIX) family of transcription factors regulates the embryonic development of the ears and kidneys. *Six2*-deficient mice display precocious ossification of synchondroses at birth due to disruptions in chondrocyte differentiation, in conjunction with reduced proliferation and accelerated terminal differentiation of the cells ([@B18]). *SIX1* is implicated in Branchiootic syndrome 3 (OMIM \#608389) and deafness (OMIM \#605192). Double knockout mice of *Six1* and *Six4* genes show a precocious partial ossification of the SOS at E18.5 ([@B18]).

Discussion {#S3}
==========

During synchondrosis development, the cross-talk between several signaling pathways, including PTHLH/PTHrP, FGF, Ihh, and Wnt/β-catenin, and control by cilium assembly and by transcription factors, play critical roles. Since the cranial abnormalities in female carriers of the P250R mutation in FGFR3 are more severe than those of the male carriers ([@B32]), it would be interesting to study whether the onset and complete ossification of synchondroses vary based on gender in wild-type and genetically modified mice. Histological analysis of precocious ossification of synchondroses indicated that the deletion of the RUNX2 inhibitors HDAC4, MEF2C, and TBX1 in mice resulted in accelerated chondrocyte differentiation and, consequently, precocious endochondral ossification of cranial synchondroses ([@B60]; [@B2]; [@B16]). Consistent with the precocious ossification of the synchondroses in these genetically modified mice, chondrogenic markers were ectopically expressed during synchondrosis formation. Since bone collar ossification occurs secondary to chondrocyte hypertrophy during endochondral bone formation ([@B8]; [@B2]), precocious ossification of synchondroses in these genetically modified mice could occur when chondrocyte hypertrophy is accelerated. The accelerated chondrocyte hypertrophy may also result in a shortage of the reserves of resting and proliferating chondrocytes.

Phenotypic Differences Between SOS and ISS {#S3.SS1}
------------------------------------------

The synchondrosis phenotype is different among genetically modified mice. Deletion of *Pthlh/Pthrp* or *Six2* or overexpression of *Runx2* in chondrocytes resulted in precocious ossification both in the ISS and the SOS. Precocious ossification is specific to the SOS in *Tbx1*-, *Fgfrl1*-, *Ihh*-, and *Pth1r-*deficient mice and *Mef2c*-superactivating mice, whereas it is specific to the ISS in *Arl6/Bbs3-*, *Evc*-, and *Evc2-*deficient mice ([Table 1](#T1){ref-type="table"}). Phenotypic differences among the synchondroses may be due to varying origins of the ISS and SOS ([Figure 1C](#F1){ref-type="fig"}). The cartilage primordium of the ISS is derived from the neural crest, whereas the SOS has a more complex origin, comprising the cartilage primordium derived from the neural crest along with the cranial mesoderm ([@B41]). TBX1 is a specific regulator of SOS development. Since TBX1 is expressed in the mesoderm-derived primordium cartilage of the SOS, differences in the expression pattern of TBX1 likely contribute to the discordant abnormalities between the ISS and SOS ([@B16]). A consequence of functional redundancy of family genes might also contribute to the same. In the synchondroses of *Ihh*-deficient mice, the hypertrophic chondrocytes in the ISS are more affected than those in the SOS ([@B64]). The remnants of the notochord express Sonic hedgehog (Shh) near the primordium of the SOS but not in the ISS. Since Shh has a redundant interaction with Ihh ([@B65]), Shh may induce the milder phenotype of the SOS than the ISS of *Ihh*-deficient mice ([@B64]).

Phenotypic Differences Between the Growth Plate and Synchondroses {#S3.SS2}
-----------------------------------------------------------------

The growth plates of cranial synchondroses and long bones contribute to bone elongation as well as shaping of the mature bone via endochondral ossification. However, the growth plate of synchondrosis and the long bone are histologically, environmentally, and developmentally different in the following aspects: (1) the mirror image growth plates of synchondrosis produce longitudinal bone growth in bipolar directions, but the growth plate of long bones produces growth in unipolar direction; (2) the long bones are overlaid by articular synovial layers, which are absent in the synchondrosis; (3) the growth plate in developing long bones present the secondary ossification center, which is absent in the synchondrosis; (4) mechanical stress influences the growth of long bones ([@B54]); and (5) the ISS originates from the neural crest, while the SOS has a complex unique contribution of both the neural crest and cranial mesoderm, and long bones are derived from mesoderm. Therefore, discordant abnormalities in the growth plates of the long bones and synchondroses are likely attributable to the differences in location-specific downstream signaling targets and the expression patterns of the signaling factors, which differ according to the unique origins and anatomical structures.

RUNX2, HDAC4, and MEF2C control endochondral ossification in the growth plates of both synchondroses and long bones ([@B58]; [@B60]; [@B2]). However, in other mutant mice, discordant abnormalities between long bones and synchondroses have been reported. Zinc finger transcriptional coregulator 521 (ZFP521), whose expression is regulated by PTHLH/PTHrP, associates with and antagonizes RUNX2 activity in chondrocytes via an HDAC4-dependent mechanism ([@B9]). Deletion of *Zfp521* in chondrocytes does not affect the synchondrosis development; however, long bones appear to be hypomorphic ([@B9]). Deletion of *Tbx1* results in precocious endochondral ossification of the SOS, but not in the skeletal cartilages despite TBX1 expression in immature chondrocytes ([@B15], [@B16]).

In the synchondroses of *Pthlh/Pthrp-*deletion mice, chondrocyte differentiation is significantly accelerated compared with those chondrocytes present in long bones ([@B22]). Ihh is expressed in prehypertrophic chondrocytes and stimulates *Pthlh/Pthrp* expression in periarticular chondrocytes in long bones. In the synchondrosis, an overlaid periarticular layer is absent, and the Ihh signaling relays cross-talks between Ihh-producing prehypertrophic chondrocytes and PTHLH/PTHrP-producing proliferating chondrocytes ([@B64]). Since PTHLH/PTHrP is expressed in both the resting and the proliferating chondrocytes in the synchondroses and in the resting chondrocytes of long bones, varied distribution of PTHLH/PTHrP-expressing chondrocytes may contribute to the discordant phenotypes between the synchondrosis and long bones of *Pthlh/Pthrp-*deficient mice ([@B64]; [@B43]).

Conclusion {#S4}
==========

Synchondroses are formed through endochondral ossification and play a critical role in the elongation of the basicranium. Deletions or activation of genes can cause the precocious ossification or hypoplasia of synchondroses, suggesting that stringent regulation of signaling pathways is crucial for proper synchondrosis development. The disruption of genes leads to both similar and distinctly different abnormalities in the development of the two synchondroses and also between the growth plates of synchondrosis and skeletal bones. Despite its importance, few studies have addressed the molecular mechanisms that regulate the endochondral ossification of synchondroses. It is important to fully elucidate the interaction of signaling pathways for the regulation of synchondrosis development. In addition, the detailed molecular mechanisms that mark the differences between the synchondroses and the skeletal bones should be deciphered. Hopefully, these insights from future studies will provide possible strategies for biologics-based therapies to treat synchondrosis anomalies.
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